Certified by Founder Lodge
Bryleos
United States - Johnson City, Tennessee
START UP
1 Disclosed Funding Rounds $5,000,000
0 Participating Investments
- Founded date
2021
- Operating Status
Active
- Last Funding Type
Seed
- Company Type
For Profit
- Website
- Contact
- Social Links
Early clinical stage therapeutics company developing BNAD101, a patent-pending oral composition of NAD+ clinically proven to increase intracellular NAD+. BNAD101 is a potential high-value me
Date | Round | Raised | Participating Investors |
---|---|---|---|
June, 14 ,2023 | Seed | $5,000,000 |